CHA₂DS₂-VA
Thromboembolic risk factors in AF, without a sex-related point.
CHA₂DS₂-VA
Principle
Assessment of thromboembolic risk factors in atrial fibrillation.
Scope
Adult atrial fibrillation. ESC 2024 CHA₂DS₂-VA variant, distinct from CHA₂DS₂-VASc. The score alone is insufficient to decide on anticoagulation; hypertrophic cardiomyopathy and cardiac amyloidosis are special situations independent of the total.
Interpretation limits
ESC 2024: 1 point is a risk indicator to consider, ≥2 an indicator of high risk. No individual risk in %, prescription or implicit conversion from VASc; reassess as the clinical situation evolves.
Formula and logic
C(1) + H(1) + exclusive age(0/1/2) + D(1) + S₂(2) + V(1). Total 0–8. No sex-related point.
Interpretation
- 0–0
- No scored factor
- 1–1
- One scored factor · assess risk
- 2–8
- Indicator of high risk
- 0–0
- No score factor present; assess special situations.
- 1–1
- ESC2024: consider oral anticoagulation.
- 2–8
- ESC2024: oral anticoagulation recommended.
Definition version : 0.3.0
Sources
- European Society of Cardiology — FA 2024 — tableau 10, CHA₂DS₂-VA ; recommandations tableau 6
2024 · 2024 definitions and exclusive age 0/1/2; without sex. Primary text read in the coauthor's copy deposited at Erasmus (page 3342), without extrapolating an individual stroke rate.
- Erasmus University Rotterdam · dépôt de coauteur — Copie intégrale des recommandations ESC FA 2024
2024 · Table 10 and recommendations table 6 on page 3342 read; hypertrophic cardiomyopathy/cardiac amyloidosis exceptions retained in the limitations.